ARPA-H SBIR Program 2026: A Complete Guide to Small Business Funding for Health Innovation

The ARPA-H SBIR program offers small businesses non-dilutive funding of up to $600,000 for Phase 1 and $3.5 million for Phase 2 to develop breakthrough health technologies. Run by the Advanced Research Projects Agency for Health (ARPA-H), it features a faster, more streamlined review process than traditional federal funding pathways — and a new solicitation is opening with a target date of June 11, 2026.

If you're a U.S.-based small business working on transformative healthcare innovation, this guide breaks down everything you need to know: what ARPA-H SBIR funds, who qualifies, the current open topics, key deadlines, and how to position a competitive application.

What is the ARPA-H SBIR program?

The ARPA-H SBIR (Small Business Innovation Research) program is a federal funding initiative designed to advance high-impact health technologies from concept to commercialization. It supports U.S. small businesses pursuing innovative R&D in areas where the agency sees the potential for transformative patient outcomes.

Alongside SBIR, ARPA-H also offers STTR (Small Business Technology Transfer) awards, which require a partnership with a research institution. Both pathways follow the same ARPA-H operating philosophy: ambitious, milestone-driven contracts rather than traditional grants — meaning continued funding depends on hitting clearly defined performance targets.

In short, ARPA-H is looking for bold ideas that can move quickly from lab to market.

How much funding does ARPA-H SBIR provide?

ARPA-H structures its small business awards in two phases:

•      Phase 1: Up to $600,000 to establish technical feasibility

•      Phase 2: Up to $3.5 million to advance development and prepare for commercialization

These amounts are higher than the SBIR caps at many other federal agencies, reflecting ARPA-H's appetite for high-risk, high-reward projects. Funding is delivered through contracts and is contingent on meeting milestones.

Who is eligible for ARPA-H SBIR and STTR awards?

Eligibility rules largely follow the federal SBIR/STTR framework, with a few ARPA-H-specific requirements.

Core requirements (both SBIR and STTR)

To qualify, a proposing organization must:

•      Be a small business with 500 or fewer employees

•      Be majority-owned by U.S. citizens or by another U.S.-based small business

•      Perform all award work within the United States

SBIR-specific requirements

•      The Principal Investigator (PI) must be more than 50% employed by the small business

•      Phase 1: The small business must perform more than 66% of the work

•      Phase 2: The small business must perform more than 50% of the work

STTR-specific requirements

•      The applicant must partner with a Research Institution (RI)

•      The PI must be more than 50% employed by either the small business or the RI

•      The small business must perform more than 40% of the work

•      The RI must perform more than 30% of the work

If you're a startup with strong academic ties, STTR is often the better fit. If your work is fully in-house, SBIR is typically the right path.

What topics is ARPA-H currently funding?

The latest draft solicitation (Notice ID: 7599226SN106) lists seven open topic areas. Proposals must address one or more of the following:

1.     Annual fertility forecasting test — A diagnostic to give women predictive insight into their future fertility.

2.     Versatile bioadhesives — Next-generation adhesives for medical applications.

3.     Universal Platform for Living Adaptive Toxin-removal (UNI-PLAT) — A flexible platform for removing toxins from the body.

4.     Curative, non-invasive, long-lasting endometriosis therapy — A first-of-its-kind treatment for endometriosis.

5.     ARPA-H Lineage Topic — A dedicated topic area within ARPA-H's lineage initiatives.

6.     Rapid comprehensive diagnostic test for multi-system autoimmune disease — Faster, more complete autoimmune diagnostics.

7.     Virtual human brain for neurosurgical robotics — A simulation platform to advance neurosurgical robotics.

Each topic represents a specific health challenge ARPA-H wants to solve at scale. Strong proposals tightly align with the technical goals laid out in the topic descriptions on SAM.gov.

What are the key dates for the ARPA-H SBIR 2026 solicitation?

Mark these milestones (all times Eastern):

Milestone	Date
Final solicitation target opening	June 11, 2026
Proposers' Day (virtual)	June 11, 2026
Proposers' Day registration closes	June 9, 2026
Solution Summary due	July 10, 2026 (11:59 PM ET)
Pitch, Cost Proposal & Task Description due	September 9, 2026 (11:59 PM ET)

Successful Solution Summary applicants are invited to pitch in the technical oral presentation phase. As always, dates are estimates — the official solicitation on SAM.gov is the source of truth.

How do you apply for ARPA-H SBIR funding?

The ARPA-H application process is intentionally lighter than legacy federal pathways, but it still rewards preparation. Here's the general flow:

8.     Review the draft solicitation on SAM.gov under Notice ID 7599226SN106 to understand the topics, evaluation criteria, and submission requirements.

9.     Attend Proposers' Day (virtual, June 11, 2026) to hear directly from program leadership and ask questions. Registration closes June 9, 2026.

10.  Submit a Solution Summary by July 10, 2026 — a concise pitch outlining the problem, your approach, and why your team can deliver.

11.  If invited, deliver a Technical Oral Presentation (pitch) along with a Cost Proposal and Task Description Document by September 9, 2026.

12.  Negotiate and execute the contract if selected, with milestones tied to continued funding.

Applications open through the ARPA-H Solutions site once the final solicitation drops.

What makes ARPA-H different from other SBIR programs?

ARPA-H operates under a unique model adapted from DARPA. A few things set it apart from NIH, NSF, or DOD SBIR pathways:

•      Higher funding ceilings than most agency SBIR programs

•      Milestone-based contracts rather than traditional grants

•      Streamlined review with a Solution Summary + pitch process instead of long written proposals

•      Strong commercialization focus, with access to ARPA-H's PATIO services, ARPANET-H Innovation Network, and partner ecosystem

•      Topic-driven solicitations focused on solving specific problems, not blue-sky research

For founders who can articulate a clear, ambitious technical vision and execute against milestones, ARPA-H tends to move faster and fund bigger than alternatives.

Frequently Asked Questions about ARPA-H SBIR

Is the ARPA-H SBIR currently accepting applications?

Not yet. The current opportunity (Notice ID 7599226SN106) is in draft solicitation status. The application portal is targeted to open on June 11, 2026, when the final solicitation is posted.

What's the difference between ARPA-H SBIR and STTR?

SBIR awards go directly to small businesses, which must perform the majority of the work. STTR awards require a formal partnership with a research institution and split the work between the two — making STTR a fit for startups commercializing university research.

Are ARPA-H SBIR awards grants or contracts?

ARPA-H SBIR funding is awarded as contracts, not grants. Continued funding depends on meeting agreed-upon milestones, consistent with the broader ARPA-H operating model.

How large can an ARPA-H SBIR award be?

Phase 1 awards are capped at approximately $600,000, and Phase 2 awards at approximately $3.5 million — significantly higher than the standard SBIR caps used by many other federal agencies.

Can foreign-owned companies apply for ARPA-H SBIR funding?

No. Applicants must be majority-owned by U.S. citizens or by another U.S.-based small business, and all work must be performed in the United States.

Where can I report SBIR-related fraud?

Suspected fraud involving SBIR awards can be reported through the NIH SEED reporting page.

Do I need a Research Institution partner to apply?

Only for STTR awards. SBIR applicants do not need an RI partner, though the Principal Investigator must be primarily employed by the small business.

Final thoughts: Should your startup pursue ARPA-H SBIR funding?

ARPA-H SBIR is one of the most attractive non-dilutive funding pathways available to U.S. health-tech startups in 2026 — but it's not for everyone. The agency funds bold, ambitious, milestone-driven projects that align with specific topic areas. If your technology fits one of the seven open topics and your team can credibly hit aggressive technical milestones, the higher funding ceilings and streamlined review process make it well worth the effort. Start by reviewing the draft solicitation on SAM.gov, registering for Proposers' Day, and shaping a Solution Summary that ties your innovation directly to the problem ARPA-H wants solved. The strongest applications are specific, evidence-backed, and built around a clear path from prototype to patient impact.